Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Inhibitory neurotransmission in the brain is largely mediated by GABA(A) receptors. Potentiation of GABA receptor activation through an allosteric benzodiazepine (BZ) site produces the sedative, anxiolytic, muscle relaxant, anticonvulsant and cognition-impairing effects of clinically used BZs such as diazepam. We created genetically modified mice (alpha1 H101R) with a diazepam-insensitive alpha1 subtype and a selective BZ site ligand, L-838,417, to explore GABA(A) receptor subtypes mediating specific physiological effects. These two complimentary approaches revealed that the alpha1 subtype mediated the sedative, but not the anxiolytic effects of benzodiazepines. This finding suggests ways to improve anxiolytics and to develop drugs for other neurological disorders based on their specificity for GABA(A) receptor subtypes in distinct neuronal circuits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, α 1-containing GABAA receptors probably mediate the sedative, amnesic, and anticonvulsant actions of classical benzodiazepines [13, 23].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [23]
Citations
Cites
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P., Montgomery, C., Geske, R., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 2,016
Wisden, W., Laurie, D., Monyer, H., & Seeburg, P. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-03-01040.1992 · Cited by 1,543
Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes.
Sieghart, W. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06840-1 · Cited by 1,301
Schwenk, F., Baron, U., & Rajewsky, K. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.24.5080 · Cited by 1,289
Fritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244
Barnard, E. A., Skolnick, P., Olsen, R. W., Möhler, H., Sieghart, W., Biggio, G., Bræstrup, C., Bateson, A. N., & Langer, S. Z. (1998) · PubMed · Cited by 1,204
Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172
Essential functions of synapsins I and II in synaptic vesicle regulation
Rosahl, T. W., Spillane, D., Missler, M., Herz, J., Selig, D. K., Wolff, J. R., Hammer, R. E., Malenka, R. C., & Südhof, T. C. (1995) · Nature · doi:10.1038/375488a0 · Cited by 719
Self-citationType I and Type II GABA A -Benzodiazepine Receptors Produced in Transfected Cells
Pritchett, D. B., Lüddens, H., & Seeburg, P. H. (1989) · Science · doi:10.1126/science.2551039 · Cited by 717
Laurie, D., Seeburg, P., & Wisden, W. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-03-01063.1992 · Cited by 667
Research works printed but not linked: 2
- Barnard, E. Subtypes of gamma-aminobutyric acid A receptors: classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50, 291–313 (1998).
- Sieghart, W. Structure and function of γ-aminobutyric acidA receptor subtypes. Pharmacol. Rev. 47, 181–234 (1995).
Cited by
Items 601–700 of 1,000
Otten, L. J., & Rugg, M. D. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02176-8 · Cited by 18
A Case of Zolpidem Dependence Successfully Detoxified with Clonazepam
Jana, A. K., Arora, M., Khess, C. R. J., & Praharaj, S. K. (2008) · American Journal on Addictions · doi:10.1080/10550490802139168 · Cited by 18
The in vivo properties of pagoclone in rat are most likely mediated by 5′-hydroxy pagoclone
Atack, J. R., Pike, A., Marshall, G. R., Stanley, J. L., Lincoln, R. J., Cook, S. M., Lewis, R. T., Blackaby, W., Goodacre, S. C., McKernan, R. M., et al. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.014 · Cited by 20
Self-citationTricyclic pyridones as functionally selective human GABAAα2/3 receptor-ion channel ligands
Crawforth, J. M., Atack, J. R., Cook, S. M., Gibson, K. R., Nadin, A. J., Owens, A. P., Pike, A. J., Rowley, M., Smith, A. J., Sohal, B., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.01.057 · Cited by 18
Self-citationMaking sense of GABAA receptor subtypes: is a new nomenclature needed?
Nutt, D. J. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105055100 · Cited by 18
Innos, J. (2013) · DSpace repository (University of Tartu) · Cited by 18
Kontić, M. Z., Dragić, M., Martinović, J., Mihajlović, K., Brkic, Z., Mitrović, N., & Grković, I. (2023) · Pharmaceuticals · doi:10.3390/ph16030331 · Cited by 17
GPR35 agonists inhibit TRPA1-mediated colonic nociception through suppression of substance P release
Gupta, R. A., Higham, J. P., Pearce, A., Urriola‐Muñoz, P., Barker, K. H., Paine, L. W., Ghooraroo, J., Raine, T., Hockley, J. R. F., Rahman, T., et al. (2024) · Pain · doi:10.1097/j.pain.0000000000003399 · Cited by 17
Yoo, J. H., Ha, T.-W., Hong, J. T., & Oh, K. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.157 · Cited by 17
Possible interplay between the theories of pharmacoresistant epilepsy
Juvale, I. I. A., & Has, A. T. C. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.15079 · Cited by 17
Spiro Benzodiazepine Substituted Fluorocoumarins as Potent Anti-Anxiety Agents
Patagar, D. N., Uttarkar, A., Patra, S. M., Patil, J. H., Kusanur, R. A., Niranjan, V., & Kumar, H. G. A. (2021) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162021020199 · Cited by 17
Hellsten, K., Sinkkonen, S. T., Hyde, T. M., Kleinman, J. E., Särkioja, T., Maksimow, A. T., Uusi‐Oukari, M., & Korpi, E. R. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.04.035 · Cited by 18
Landry, P., Gervais, M., & O’Connor, K. P. (2008) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2008.06.008 · Cited by 17
Kawaharada, S., Nakanishi, M., Nakanishi, N., Hazama, K., Higashino, M., Yasuhiro, T., Lewis, A., Clark, G. S., Chambers, M. S., Maidment, S. A., et al. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.247627 · Cited by 17
Rajagopal, L., Huang, M., Michael, E., Kwon, S., & Meltzer, H. Y. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0160-3 · Cited by 17
Contribution of GABAA receptor subunits to attention and social behavior
Paine, T. A., Chang, S., & Poyle, R. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112261 · Cited by 17
Pyrazolopyridinones as functionally selective GABAA ligands
Blackaby, W., Atack, J. R., Bromidge, F. A., Lewis, R. T., Russell, M. G. N., Smith, A. J., Wafford, K. A., McKernan, R. M., Street, L. J., & Castro, J. L. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.08.006 · Cited by 17
Self-citationCholinergic Nicotinic Systems in Alzheimer??s Disease: Prospects for Pharmacological Intervention
Vesey, R., Birrell, J. M., Bolton, C., Chipperfield, R. S., Blackwell, A. D., Dening, T., & Sahakian, B. J. (2002) · CNS Drugs · doi:10.2165/00023210-200216070-00005 · Cited by 17
Ujfalussy, B. B., Kiss, T., Orbán, G., Hoffmann, W. E., Érdi, P., & Hajós, M. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.09.022 · Cited by 17
Selective GABAA circuits for novel CNS drugs
Möhler, H., & Rudolph, U. (2004) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2004.08.019 · Cited by 17
Ren, X., Wang, Q., Zhang, X., Wang, G., Liu, T., Deng, N., & Yan, D. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9080 · Cited by 16
Umbricht, D., Kas, M. J., & Dawson, G. R. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.08.511 · Cited by 17
Self-citationGABAA Alpha 2,3 Modulation Improves Select Phenotypes in a Mouse Model of Fragile X Syndrome
Schaefer, T. L., Ashworth, A. A., Tiwari, D., Tomasek, M. P., Parkins, E. V., White, A. R., Snider, A., Davenport, M. H., Grainger, L. M., Becker, R. A., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.678090 · Cited by 16
Clinical Pharmacokinetics and Pharmacodynamics of Anxiolytics and Sedative/Hypnotics
DeVane, C. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-27883-4_10 · Cited by 16
Yuan, N. Y., Poe, M. M., Witzigmann, C., Cook, J. M., Stafford, D. C., & Arnold, L. A. (2016) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2016.08.006 · Cited by 16
Zolpidem is a potent anticonvulsant in adult and aged mice
Vlainić, J., & Peričić, D. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.018 · Cited by 16
Firing of Hippocampal Neurogliaform Cells Induces Suppression of Synaptic Inhibition
Li, G., Stewart, R. G., Canepari, M., & Capogna, M. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3046-13.2014 · Cited by 16
Basic Mechanisms of Psychotropic Drugs
Ebert, U. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.043s2002.x · Cited by 16
Gene sequencing for identification of Paragonimus eggs from a human case.
Chang, Z.-S., Wu, B., Blair, D., Zhang, Y. N., Hu, L., Chen, S. H., Chen, M. G., Feng, Z., & Davis, G. M. (2000) · PubMed · Cited by 16
Mechanisms of Antiepileptic Drug Action
Walker, M. C., & Fisher, A. (2004) · Wiley eBooks · doi:10.1002/9780470752463.ch9 · Cited by 16
Mitchell, C. P., Grayson, D. R., & Goldman, M. B. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.09.017 · Cited by 16
Morris, H. V., Nilsson, S. R. O., Dixon, C. I., Stephens, D. N., & Clifton, P. G. (2009) · Appetite · doi:10.1016/j.appet.2009.03.006 · Cited by 16
Carter, L. P., Griffiths, R. R., Suess, P. E., Casada, J. H., Wallace, C. L., & Roache, J. D. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.119693 · Cited by 16
Kohut, S. J., & Ator, N. A. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.02.019 · Cited by 16
Nag, S., Mishra, A., & Batra, S. (2008) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200800448 · Cited by 16
Designer genes and anti-anxiety drugs
Tecott, L. H. (2000) · Nature Neuroscience · doi:10.1038/75692 · Cited by 16
Agarwal, P., Misra, M., Sarkari, N. B. S., Gupta, A. K., & Agarwal, P. (1998) · PubMed · Cited by 16
Durkin, E., Muessig, L., Herlt, T., Lumb, M. J., Patel, R., Thomas, P., Bright, D. P., Jurd, R., Moss, S. J., Dickenson, A. H., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/462457 · Cited by 16
Hsu, Y., Chang, Y., Chang, C., Siew, J. J., Chen, H., Tsai, C., & Chern, Y. (2017) · Movement Disorders · doi:10.1002/mds.27107 · Cited by 15
Pflanz, N. C., Daszkowski, A. W., Cornelison, G. L., Trudell, J. R., & Mihic, S. J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002128 · Cited by 15
Bakker, C., van Esdonk, M. J., Stuurman, R., Borghans, L. G. J. M., de Kam, M. L., van Gerven, J., & Groeneveld, G. J. (2021) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1913 · Cited by 15
Beek, E. T. T., Chen, X., Jacobs, G. E., Nahon, K. J., de Kam, M. L., Lappalainen, J., Cross, A. J., van Gerven, J., & Hay, J. L. (2014) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.134 · Cited by 15
de Almeida, R. M. M., Benini, Q., Betat, J., Hipólide, D. C., Miczek, K. A., & Svensson, A. I. (2007) · Psychopharmacology · doi:10.1007/s00213-007-1031-5 · Cited by 15
Liu, C., Lin, Y.-R., Chan, M., & Chen, H. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl168 · Cited by 15
GABAA receptor modulators as anxioselective anxiolytics
Basile, A. S., LIPPA, A. S., & Skolnick, P. (2006) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2006.10.009 · Cited by 15
Carling, R. W., Russell, M. G. N., Moore, K. W., Mitchinson, A., Guiblin, A. R., Smith, A. J., Wafford, K. A., Marshall, G. R., Atack, J. R., & Street, L. J. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.03.081 · Cited by 15
Self-citationTP003 is a non-selective benzodiazepine site agonist that induces anxiolysis via α2GABAA receptors
Neumann, E., Ralvenius, W. T., Acuña, M. A., Rudolph, U., & Zeilhofer, H. U. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.026 · Cited by 14
Li, D., Chang, Y., Chen, Y., & Yen, C. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17113870 · Cited by 14
Hansen, R. R., Erichsen, H. K., Brown, D. T., Mirza, N. R., & Munro, G. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.08.002 · Cited by 14
Huskinson, S. L., Freeman, K. B., & Rowlett, J. K. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05286-0 · Cited by 14
Evaluation of Anticonvulsant Effect of Aqueous and Methanolic Extracts of Seven Inula Species.
Ekbatan, M. R., Khoramjouy, M., Gholamine, B., Faizi, M., & Sahranavard, S. (2019) · PubMed Central · doi:10.22037/ijpr.2019.15509.13151 · Cited by 14
García, P. S., Whalin, M. K., & Sebel, P. S. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1679-5.00009-0 · Cited by 14
Vinkers, C. H., Cryan, J. F., Olivier, B., & Groenink, L. (2010) · The Open Pharmacology Journal · doi:10.2174/1874143601004010001 · Cited by 14
Stereoselective discriminative stimulus effects of zopiclone in rhesus monkeys
McMahon, L. R., Jerussi, T. P., & France, C. P. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1286-9 · Cited by 14
Benzodiazepine site inverse agonists and locomotor activity in rats: Bimodal and biphasic influence
Savić, M. M., Obradovic, D. I., Ugrešić, N. D., Cook, J. M., Yin, W., Linn, M., & Bokonjić, D. R. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.04.001 · Cited by 15
Influence of diltiazem on the behavior of zolpidem-treated mice in the elevated-plus maze test
Cui, X.-Y., Zhao, X., Chu, Q.-P., Chen, B.-Q., & Zhang, Y.-H. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0535-1 · Cited by 14
Pharmacology of the GABA A Receptor
Berezhnoy, D., Gravielle, M. C., & Farb, D. H. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn012 · Cited by 14
New Insights Into Pharmacology of GABAA Receptor Alpha Subunits–Selective Modulators
Moraru, M. V., Stoleru, S., Zugravu, A., Coman, O. A., & Fulga, I. (2024) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001810 · Cited by 13
Wu, J., Zhao, M., Jin, Y., Li, M., Yu, K.-X., & Yu, H. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01195-3 · Cited by 13
Gogas, K. R., Lechner, S. M., Markison, S., Williams, J. P., McCarthy, W. C., Grigoriadis, D. E., & Foster, A. C. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00164-4 · Cited by 13
Protein complexes as psychiatric and neurological drug targets
Kato, A., & Witkin, J. M. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.018 · Cited by 13
Zarezin, D. P., & Nenajdenko, V. G. (2018) · Russian Chemical Reviews · doi:10.1070/rcr4852 · Cited by 13
Sheikhi, M., Shirzadian, A., Dehdashtian, A., Amiri, S., Ostadhadi, S., Ghasemi, M., & Dehpour, A. R. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.07.014 · Cited by 13
Liu, M., & Glowa, J. R. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02962-0 · Cited by 13
The Chemistry of Benzodiazepines
Valdés, C., & Bayod, M. (2011) · Wiley eBooks · doi:10.1002/9783527637737.ch25 · Cited by 13
McMahon, L. R., Javors, M. A., & France, C. P. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0692-9 · Cited by 13
Discriminative Stimulus Effects of Benzodiazepine (BZ)1 Receptor-Selective Ligands in Rhesus Monkeys
McMahon, L. R., Gerak, L. R., Carter, L. C., Ma, C., Cook, J. M., & France, C. P. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.505 · Cited by 13
α2‐containing GABAA receptors expressed in hippocampal region CA3 control fast network oscillations
Heistek, T. S., Ruiperez‐Alonso, M., Timmerman, A., Brussaard, A. B., & Mansvelder, H. D. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.243725 · Cited by 12
Sharma, D., Dixit, A. B., Dey, S., Tripathi, M., Doddamani, R. S., Sharma, M. C., Lalwani, S., Gurjar, H. K., Chandra, P. S., & Banerjee, J. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105084 · Cited by 12
Aquizerate, A., Laforgue, E., Istvan, M., Rousselet, M., Gérardin, M., Jouanjus, É., Libert, F., French Addictovigilance Network, Caous, A., Chaouachi, L., et al. (2023) · European Journal of Public Health · doi:10.1093/eurpub/ckad003 · Cited by 12
Designer Benzodiazepines: Effects, Toxicity, and Interactions
Balkhi, S. E., & Abbara, C. (2023) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000001071 · Cited by 12
Karam, H. M., & Radwan, R. R. (2020) · Environmental Toxicology · doi:10.1002/tox.22949 · Cited by 12
Licata, S. C., Platt, D. M., Rüedi‐Bettschen, D., Atack, J. R., Dawson, G. R., Linn, M. L. V., Cook, J. M., & Rowlett, J. K. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.10.004 · Cited by 12
Self-citationVijayan, R., & Ghoshal, N. (2008) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2008.05.003 · Cited by 12
Benzodiazepine receptor ligands: a patent review (2006 – 2012)
Guerrini, G., & Ciciani, G. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.782005 · Cited by 13
Phasic GABAA-Mediated Inhibition
Cherubini, E. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.003.0008 · Cited by 12
Acute toxicity and sleep-wake EEG analysis of Stachtarpheta cayennensis (Verbenaceae) in rodents
Akanmu, M., Olayiwola, G., Ukponmwan, O., & Honda, K. (2005) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.4314/ajtcam.v2i3.31118 · Cited by 12
Sedative and anticonvulsant effects of zolpidem in adult and aged mice
Peričić, D., Vlainić, J., & Štrac, D. Š. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0020-0 · Cited by 12
New directions in the treatment of anxiety disorders
Hood, S. D., Argyropoulos, S. V., & Nutt, D. (2003) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.13.4.401 · Cited by 12
GABA and Sleep: Molecular, Functional and Clinical Aspects
Reite, M. L. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010133 · Cited by 12
Szodorai, E., Bampali, K., Romanov, R. A., Kasper, S. F., Hökfelt, T. G. M., Ernst, M. C., Lübec, G., & Harkany, T. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.07.003 · Cited by 11
Molecular docking analysis of α2-containing GABAA receptors with benzimidazoles derivatives
Bouayyadi, A., Aliani, A. E., Kasmi, Y., Moussaif, A., Abbadi, N. E., Mesfioui, A., Essassi, E. M., & Mzibri, M. E. (2020) · Bioinformation · doi:10.6026/97320630016611 · Cited by 11
A importância da formação do professor de Matemática para a inclusão de alunos com discalculia
Araújo, K. L. D. S., & Bazante, T. M. G. D. (2020) · Revista de Ensino de Ciências e Matemática · doi:10.26843/10.26843/rencima.v11i7.2647 · Cited by 11
Mundy, P. C., Pressly, B., Carty, D. R., Yaghoobi, B., Wulff, H., & Lein, P. J. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115643 · Cited by 11
1,5‐Benzodiazepines as a platform for the design of carbonic anhydrase inhibitors
Ismail, C., Nocentini, A., Supuran, C. T., Winum, J., & Gharbi, R. (2021) · Archiv der Pharmazie · doi:10.1002/ardp.202100405 · Cited by 11
Zaleplon-induced Anemsic Somnambulism with Eating Behaviors Under Once Dose.
Chen, Y., Tseng, P., Wu, C.-K., & Chen, C.-C. (2014) · PubMed · Cited by 11
Woo, J. H., Ha, T.-W., Kang, J.-S., Hong, J. T., & Oh, K. (2017) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2017.21.1.27 · Cited by 11
Lin, S.-F., Bois, F., Holden, D., Nabulsi, N., Pracitto, R., Gao, H., Kapinos, M., Teng, J.-K., Shirali, A. R., Ropchan, J. R., et al. (2017) · Molecular Imaging · doi:10.1177/1536012117731258 · Cited by 11
Gurrell, R., Whitlock, M., Wei, H., Shen, Z., & Ogden, A. G. (2021) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.912 · Cited by 11
GABA α6 receptors mediate midazolam-induced anxiolysis
Hoffman, W. E., Balyasnikova, I. V., Mahay, H., Danilov, S. M., & Baughman, V. L. (2002) · Journal of Clinical Anesthesia · doi:10.1016/s0952-8180(02)00343-4 · Cited by 11
M�hler, H. (2006) · Informa Healthcare eBooks · doi:10.1201/9781420016185.sec2 · Cited by 11
Lüddens, H. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_56 · Cited by 11
Polsky-Fisher, S. L., Vickers, S., Cui, D., Subramanian, R., Arison, B. H., Agrawal, N. G. B., Goel, T. V., Vessey, L. K., Murphy, M. G., Lasseter, K. C., et al. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008193 · Cited by 11
Effects of lorazepam and oxazepam on perceptual and procedural memory functions
Martin, J., Matthews, A. J., Martin, F. H., Kirkby, K. C., Alexander, J., & Daniels, B. A. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1220-1 · Cited by 11
Functional Relevance of GABAA-Receptor Subtypes
Möhler, H. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-465-0_2 · Cited by 11
Phasic GABAA‐mediated inhibition
Cherubini, E. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02799.x · Cited by 10
Arias, H. R., do Rego, J. L., do Rego, J. L., Chen, Z., Anouar, Y., Scholze, P., Gonzales, E. B., Huang, R., & Chagraoui, A. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109930 · Cited by 10
Xie, F., Zhang, B., Chen, Y., Jia, H.-W., Sun, L., Zhuang, K., Yin, L., Cheng, M., Lin, B., & Liu, Y. (2020) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.202000755 · Cited by 10
In Vivo Evidence of the Specificity of Effects of GABAA Receptor Modulating Medications
Krystal, A. D. (2010) · SLEEP · doi:10.1093/sleep/33.7.859 · Cited by 10
Fischer, B. D., Platt, D. M., Rallapalli, S., Namjoshi, O. A., Cook, J. M., & Rowlett, J. K. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.10.026 · Cited by 10
Metadata
- Authors
- McKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., Garrett, L., Bristow, L., Marshall, G., Macaulay, A., Brown, N., Howell, O., Moore, K. W., Carling, R. W., Street, L. J., Castro, J. L., Ragan, C. I., Dawson, G. R., & Whiting, P. J.
- Affiliations
- MSD (UK) Limited (United Kingdom) (GB)
- Corresponding author
- McKernan, R. M.
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2000-06
- Volume
- 3
- Issue
- 6
- Pages
- 587-592
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2001619275
- Cited by
- 944
- References
- 35
- Citations by year
- 2026: 11 · 2025: 8 · 2024: 18 · 2023: 23 · 2022: 14 · 2021: 23 · 2020: 30 · 2019: 24 · 2018: 37 · 2017: 22 · 2016: 30 · 2015: 29 · 2014: 32 · 2013: 36 · 2012: 37
- FWCI
- 19.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Keywords
- benzodiazepines, GABAA receptor, alpha1 subunit, sedation, anxiolytic effects, genetically modified mice, inhibitory neurotransmission, diazepam
- MeSH terms
- Allosteric Site, Animals, Anticonvulsants, Azides, Benzodiazepines, Binding, Competitive, Brain, Cell Line, Diazepam, Dose-Response Relationship, Drug, Flumazenil, Fluorobenzenes, Hypnotics and Sedatives, Ligands, Mice, Inbred C57BL, Mice, Mutant Strains, Motor Activity, Receptors, GABA-A, Reflex, Startle, Anti-Anxiety Agents, Triazoles, Patch-Clamp Techniques, Mice, GABA-A Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.